Not applicableStudy completedNCT01049399
What this trial is testing
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Who this might be right for
Progressive Supranuclear Palsy
Noscira SA 146